Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Novo Nordisk A/S
Index- P/E32.88 EPS (ttm)1.75 Insider Own- Shs Outstand2.02B Perf Week1.39%
Market Cap116.01B Forward P/E25.93 EPS next Y2.22 Insider Trans- Shs Float1.90B Perf Month2.37%
Income4.58B PEG2.12 EPS next Q- Inst Own10.10% Short Float0.24% Perf Quarter23.06%
Sales14.36B P/S8.08 EPS this Y7.80% Inst Trans2.24% Short Ratio2.85 Perf Half Y30.63%
Book/sh1.87 P/B30.77 EPS next Y19.05% ROA41.30% Target Price75.00 Perf Year36.07%
Cash/sh0.54 P/C106.90 EPS next 5Y15.50% ROE81.30% 52W Range41.08 - 57.70 Perf YTD38.10%
Dividend0.73 P/FCF53.02 EPS past 5Y23.00% ROI65.50% 52W High-0.28% Beta0.91
Dividend %1.27% Quick Ratio0.70 Sales past 5Y11.70% Gross Margin84.00% 52W Low40.08% ATR0.74
Employees39062 Current Ratio1.00 Sales Q/Q23.90% Oper. Margin40.50% RSI (14)66.21 Volatility1.07% 1.19%
OptionableYes Debt/Eq0.02 EPS Q/Q54.10% Profit Margin31.40% Rel Volume0.66 Prev Close57.63
ShortableYes LT Debt/Eq0.00 EarningsApr 30 BMO Payout45.30% Avg Volume1.57M Price57.54
Recom2.00 SMA201.83% SMA506.02% SMA20022.76% Volume1,030,610 Change-0.16%
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Feb-08-08Upgrade Bernstein Mkt Perform → Outperform
Jan-23-08Upgrade Bear Stearns Peer Perform → Outperform
May-20-15 12:08PM  Novo Nordisk, Baxter clash over haemophilia drug patent Reuters
10:52AM  Novo Nordisk rejects Baxter patent claim over Novoeight Reuters
10:40AM  China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR Newswire
May-18-15 04:59PM  SLU vs. Bothell: The region's two hot biotech real estate markets go head to head at
May-17-15 11:36AM  Billionaire Jim Simons Top Holdings: Inc. (AMZN), Colgate-Palmolive Company and More at Insider Monkey
May-14-15 09:35AM  UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner at Insider Monkey
May-08-15 04:21PM  Healthcare Winners and Losers: May 8, 2015
May-06-15 06:00AM  Hot Drugs Show Sharp Price Hikes in Shadow Market
06:00AM  Diabetes Drugs Compete With Prices That Rise in Lockstep at Bloomberg
May-05-15 01:16PM  Healthcare Mid-Day Winners and Losers: May 05, 2015
12:51PM  Healthcare AM Winners and Losers: May 05, 2015
12:46PM  Healthcare AM Winners and Losers: May 04, 2015
12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
12:46PM  Healthcare Winners and Losers: May 04, 2015
May-04-15 03:41PM  Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog
May-03-15 11:28PM  Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE
01:26PM  5 Trade Ideas for Monday: Fastenal, Goodyear, Northern Trust, Novo Nordisk & NXP Semi
Apr-30-15 06:50PM  Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
10:48AM  Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings at Investor's Business Daily
07:08AM  European drugmakers lifted by weak euro at Financial Times
Apr-22-15 11:44AM  Economic Sentiment up in the Eurozone: EWG up 0.88%, FEZ up 0.46%
11:27AM  Novo launches Saxenda in US, sees more launches in 2015 Reuters
10:38AM  Novo Nordisk says Saxenda obesity drug to cost $1,068 per month
09:23AM  3 Large-Cap Pharmaceutical Companies to Invest in Right Now at TheStreet
Apr-13-15 05:09PM  Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog
Apr-09-15 01:40PM  Novo Nordisk's Tresiba & Ryzodeg NDAs under FDA Review - Analyst Blog
Apr-01-15 02:46PM  Hedge Funds Made A Bundle By Betting On, Inc. (AMZN), Apple, and Pfizer Inc at Insider Monkey
10:40AM  FDA Urged to Fine Drugmakers Over Ads at Fox Business
08:01AM  Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 March 2015) Globe Newswire Europe
Mar-31-15 03:43PM  Top First Quarter European ETFs
Mar-30-15 07:00AM  The Best and Worst Medalists of 2015's First Quarter at Morningstar
Mar-29-15 06:17PM  Novo Nordisks Insulin Move Is Right Medicine at The Wall Street Journal
Mar-27-15 11:39PM  Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons Holdings for Long-Run at Insider Monkey
06:15PM  Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog
03:10PM  Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog
02:18PM  Insulin: moving the needle at Financial Times
01:15PM  European stocks snap win streak; DAX logs first weekly loss in 2 months at MarketWatch
11:19AM  Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source Reuters
11:06AM  European shares set for 2015's biggest weekly fall despite Novo Nordisk surge Reuters
09:40AM  Novo Nordisk's Insulin Move Is Right Medicine at The Wall Street Journal
08:13AM  Can The Uptrend Continue for Novo Nordisk (NVO)? - Tale of the Tape
07:39AM  Novo Nordisk surge buoys European shares after two-day slide Reuters
07:39AM  March 27 Premarket Briefing: 10 Things You Should Know
07:25AM  Cruise news you can use, plus more Friday business headlines at
06:10AM  European Stocks Rebound From Two-Day Drop
04:41AM  Novo Nordisk Soars on Plan to Resubmit Rejected Insulin in U.S. at Bloomberg
Mar-26-15 06:49PM  Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog +6.90%
06:40PM  Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
06:36PM  Red Hat, Signet Top Buy Points En Route To New Highs at Investor's Business Daily
04:01PM  Novo Nordisk (NVO) Stock Gains Today on Drug Application Resubmission at TheStreet
01:57PM  Novo Nordisk to Refile Tresiba in the U.S. on Interim Analysis at Bloomberg
11:46AM  The Investor's Solution to Low, Low Interest Rates: Part I at Forbes
08:55AM  Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog
Mar-24-15 01:40PM  Novo Nordisk's Saxenda Gets EU Approval for Obesity - Analyst Blog
08:47AM  Bristol-Myers in Autoimmune Program Deal at The Wall Street Journal
Mar-19-15 04:10PM  Pfizer Announces Publication of CAPiTA Data on Prevenar 13 - Analyst Blog
10:38AM  Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better" at Forbes
Mar-18-15 05:10PM  Valeant (VRX) Prices Shares to Finance Salix Acquisition - Analyst Blog
03:38PM  AstraZeneca Presents Encouraging Heart Drug Brilinta Data - Analyst Blog
02:20PM  Novartis' Jakavi Gets EC Approval for Polycythemia Vera - Analyst Blog
10:53AM  Novo Nordisk A/S - Share repurchase programme at noodls
Mar-17-15 12:17AM  Weight-Loss Drugs Seek Acceptance From Patients and Physicians at The Wall Street Journal
Mar-16-15 01:17PM  Weight-Loss Drugs Try Again at The Wall Street Journal
Mar-09-15 05:06PM  Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog
Mar-06-15 03:16AM  Novo Nordisk A/S gennemfører succesfuld børsnotering af NNIT A/S at noodls
Feb-23-15 05:23PM  Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog
Feb-20-15 11:42AM  Novo Nordisk Pops On Successful Diabetes Drug Trial at Investor's Business Daily +5.27%
Feb-12-15 01:40PM  Baxter Announces Positive Data for BAX 855; Competition Rife - Analyst Blog
Feb-06-15 09:00AM  On MannKind, Diabetics Have One Up On Wall Street at Forbes
Feb-05-15 10:47AM  Novo Nordisk files annual report with the SEC at noodls
Feb-03-15 09:47PM  Sale of Seattle BioMed, Juno building sets Seattle price record at
07:00AM  Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-02-15 09:46AM  Novo Nordisk's Q4 Earnings Rise Y/Y, Provides 2015 Outlook - Analyst Blog Zacks
Jan-30-15 08:59AM  Diabetics: Use Your Firsthand Experience To Beat Wall Street at Forbes
Jan-28-15 06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at
Jan-27-15 03:30PM  Afrezza Breathes Life Into MannKind at Forbes
Jan-26-15 02:03PM  Novo Nordisk stock rises 3% at MarketWatch
01:39PM  4 Stocks Spiking on Unusual Volume: Novo Nordisk and More at TheStreet
Jan-20-15 02:10PM  Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Zacks
01:41PM  Three Companies That Should Benefit From a Stronger U.S. Dollar at TheStreet
Jan-14-15 04:42PM  CSE Enjoys Record Year in 2014, International Outreach and Trading Initiatives Help Shape Agenda for New Year Marketwired
01:55PM  5 Obesity Stocks Investors Are Watching Benzinga
Jan-13-15 03:22PM  Pharma Grows Itself a New Challenge -- Overheard at The Wall Street Journal
Jan-05-15 12:18AM  Overheard: Novo Nordisks Weighty Issue at The Wall Street Journal
Jan-04-15 02:31PM  [$$] Overheard: Novo Nordisk's Weighty Issue at The Wall Street Journal
11:32AM  Novo Nordisk Shapes Up for New Year at The Wall Street Journal
Jan-02-15 08:40AM  Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares Globe Newswire Europe
Dec-30-14 09:43AM  Eminence Capital raises position in CBS Outdoor Americas Inc. Market Realist
Dec-26-14 12:35PM  4 Potential Blockbuster Drugs The FDA Just Approved at Investor's Business Daily
Dec-24-14 09:31AM  Stocks to Watch: American Realty, Brink's, Novo Nordisk, TECO at The Wall Street Journal
09:23AM  Cramer's Mad Dash: Pharma movers CNBC
Dec-08-14 04:54PM  How To Profit From The Obesity Epidemic Benzinga
Dec-05-14 05:39PM  Paralegal: Sanofi fired her for whistleblowing AP
Dec-04-14 12:13PM  A Look At 4 ETFs From The 4 'Least Corrupt' Countries Benzinga
Dec-01-14 10:09AM  Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013 PR Newswire
Nov-26-14 06:55AM  [$$] Novo Could Put Money Where Its Mouth Is at The Wall Street Journal
Nov-24-14 05:15PM  Novo Nordisk's Victoza Recommended for Label Expansion Zacks
07:00AM  Sanofi Shakes Off Patent Losses Morningstar
Nov-20-14 11:44AM  Sanofi's Bullish Pipeline Forecast Underwhelms Street at Investor's Business Daily
Nov-04-14 05:43PM  Media Release - Top 100 Employer CNW Group
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.